Is there an issue? Send a MessageReason:
None
Added DiffLines:
!!This recap contains unmarked SPOILERS per [[Administrivia/SpoilersOff policy]]. Administrivia/YouHaveBeenWarned
Is there an issue? Send a MessageReason:
None
Changed line(s) 1,2 (click to see context) from:
Two college students commit suicide after taking part in clinical trials for an experimental antidepressant. The lead researcher is found to have covered up reports of side-effects among the test subjects. Southerlyn learns that Barden Pharmaceuticals, the company funding the study, may have suppressed data from other trials which showed the drug to be harmful. But the CEO, Dr. Cedars, refuses to disclose that information. When it's discovered that multiple trials abroad showed that the drug causes patients to become suicidal, Barden Pharmaceuticals is charged with the murders of the students. Baden tries to get its clinical studies suppressed on the grounds of protecting trade secrets, but the judge overrules this.
to:
Two college students commit suicide after taking part in clinical trials for an experimental antidepressant. The lead researcher is found to have covered up reports of side-effects among the test subjects. Southerlyn learns that Barden Pharmaceuticals, the company funding the study, may have suppressed data from other trials which showed the drug to be harmful. But the CEO, Dr. Cedars, refuses to disclose that information. When it's discovered that multiple trials abroad showed that the drug causes patients to become suicidal, Barden Pharmaceuticals is charged with the murders of the students. Baden Barden tries to get its clinical studies suppressed on the grounds of protecting trade secrets, but the judge overrules this.
Is there an issue? Send a MessageReason:
None
Changed line(s) 1,4 (click to see context) from:
Two college students commit suicide after taking part in clinical trials for an experimental antidepressant. The lead researcher is found to have covered up reports of side-effects among the test subjects. Southerlyn learns that Barden Pharmaceuticals, the company funding the study, may have suppressed data from other trials which showed the drug to be harmful. But the CEO, Dr. Cedars, refuses to disclose that information. When it's discovered that multiple trials abroad showed that the drug causes patients to become suicidal, Barden Pharmaceuticals is charged with the murders of the students. The judge rules that details from clinical studies are admissible as long as certain information is redacted to protect trade secrets.
[=McCoy=] calls several convincing witnesses, including another student who attempted suicide after participating in the trial. But the jury is swayed by an expert testimony in favor of Barden. Barden's lawyers also get a key piece of evidence suppressed that proves Cedars wanted the trials to continue so he could get an extension on his patent for the drug. With no guarantee as to how a jury would rule, Branch tells [=McCoy=] to cut a deal with Cedars. Not wanting to risk a lengthy prison sentence, Cedars reluctantly agrees to make all data from his clinical studies accessible through a medical database in exchange for dropping the criminal charges. But Barden still faces a class action civil suit that could bankrupt them, and Branch reflects that letting them go out of business may not be the right thing to do.
[=McCoy=] calls several convincing witnesses, including another student who attempted suicide after participating in the trial. But the jury is swayed by an expert testimony in favor of Barden. Barden's lawyers also get a key piece of evidence suppressed that proves Cedars wanted the trials to continue so he could get an extension on his patent for the drug. With no guarantee as to how a jury would rule, Branch tells [=McCoy=] to cut a deal with Cedars. Not wanting to risk a lengthy prison sentence, Cedars reluctantly agrees to make all data from his clinical studies accessible through a medical database in exchange for dropping the criminal charges. But Barden still faces a class action civil suit that could bankrupt them, and Branch reflects that letting them go out of business may not be the right thing to do.
to:
Two college students commit suicide after taking part in clinical trials for an experimental antidepressant. The lead researcher is found to have covered up reports of side-effects among the test subjects. Southerlyn learns that Barden Pharmaceuticals, the company funding the study, may have suppressed data from other trials which showed the drug to be harmful. But the CEO, Dr. Cedars, refuses to disclose that information. When it's discovered that multiple trials abroad showed that the drug causes patients to become suicidal, Barden Pharmaceuticals is charged with the murders of the students. The judge rules that details from Baden tries to get its clinical studies are admissible as long as certain information is redacted to protect suppressed on the grounds of protecting trade secrets.
secrets, but the judge overrules this.
[=McCoy=] calls several convincing witnesses, including another student who attempted suicide after participating in the drug trial. But the jury is swayed by an expert testimony in favor of Barden. Barden's lawyers also get a key piece of evidence suppressed that proves Cedars wanted the trials to continue so he could get an extension on his patent for the drug. With no guarantee as to how a jury would rule, Branch tells [=McCoy=] to cut a deal with Cedars. Not wanting to risk a lengthy prison sentence, Cedars reluctantly agrees to make alldata from of his clinical studies accessible through a medical database in exchange for dropping the criminal murder charges. But Barden still faces a class action civil suit that could bankrupt them, and Branch reflects that letting them go out of business may not be the right thing to do.
[=McCoy=] calls several convincing witnesses, including another student who attempted suicide after participating in the drug trial. But the jury is swayed by an expert testimony in favor of Barden. Barden's lawyers also get a key piece of evidence suppressed that proves Cedars wanted the trials to continue so he could get an extension on his patent for the drug. With no guarantee as to how a jury would rule, Branch tells [=McCoy=] to cut a deal with Cedars. Not wanting to risk a lengthy prison sentence, Cedars reluctantly agrees to make all
Is there an issue? Send a MessageReason:
None
Changed line(s) 7 (click to see context) from:
* DoubleMeaningTitle
to:
* DoubleMeaningTitleDoubleMeaningTitle: Refers both to the victims (who jumped to their deaths from windows) and the question of whether the prosecution of Barden is unnecessarily harsh.
Added DiffLines:
* TheNeedsOfTheMany: A key facet of the case is the question of whether the risks of medical trials outweigh the potential for saving lives.
Is there an issue? Send a MessageReason:
None
Added DiffLines:
Two college students commit suicide after taking part in clinical trials for an experimental antidepressant. The lead researcher is found to have covered up reports of side-effects among the test subjects. Southerlyn learns that Barden Pharmaceuticals, the company funding the study, may have suppressed data from other trials which showed the drug to be harmful. But the CEO, Dr. Cedars, refuses to disclose that information. When it's discovered that multiple trials abroad showed that the drug causes patients to become suicidal, Barden Pharmaceuticals is charged with the murders of the students. The judge rules that details from clinical studies are admissible as long as certain information is redacted to protect trade secrets.
[=McCoy=] calls several convincing witnesses, including another student who attempted suicide after participating in the trial. But the jury is swayed by an expert testimony in favor of Barden. Barden's lawyers also get a key piece of evidence suppressed that proves Cedars wanted the trials to continue so he could get an extension on his patent for the drug. With no guarantee as to how a jury would rule, Branch tells [=McCoy=] to cut a deal with Cedars. Not wanting to risk a lengthy prison sentence, Cedars reluctantly agrees to make all data from his clinical studies accessible through a medical database in exchange for dropping the criminal charges. But Barden still faces a class action civil suit that could bankrupt them, and Branch reflects that letting them go out of business may not be the right thing to do.
!!!This episode contains examples of:
* DoubleMeaningTitle
* DrivenToSuicide: Several people who took part in the clinical trials.
* EvilInc: Barden Pharmaceuticals
* MyGodWhatHaveIDone: [=McCoy=]'s witness describes feeling like this after she attempted suicide whilst taking the drug.
* TheReasonYouSuckSpeech: Cedars gives one, claiming that [=McCoy=] is simply trying to ruin his business and doesn't care that drug companies' profits go to fund life-saving treatments.
[=McCoy=] calls several convincing witnesses, including another student who attempted suicide after participating in the trial. But the jury is swayed by an expert testimony in favor of Barden. Barden's lawyers also get a key piece of evidence suppressed that proves Cedars wanted the trials to continue so he could get an extension on his patent for the drug. With no guarantee as to how a jury would rule, Branch tells [=McCoy=] to cut a deal with Cedars. Not wanting to risk a lengthy prison sentence, Cedars reluctantly agrees to make all data from his clinical studies accessible through a medical database in exchange for dropping the criminal charges. But Barden still faces a class action civil suit that could bankrupt them, and Branch reflects that letting them go out of business may not be the right thing to do.
!!!This episode contains examples of:
* DoubleMeaningTitle
* DrivenToSuicide: Several people who took part in the clinical trials.
* EvilInc: Barden Pharmaceuticals
* MyGodWhatHaveIDone: [=McCoy=]'s witness describes feeling like this after she attempted suicide whilst taking the drug.
* TheReasonYouSuckSpeech: Cedars gives one, claiming that [=McCoy=] is simply trying to ruin his business and doesn't care that drug companies' profits go to fund life-saving treatments.
